Screening for disease susceptibility by genotyping the CCR5 and CCR2 genes

Abstract

Provided are compositions, methods and uses for identifying persons at an increased risk of infection by, transmission of, or accelerated progression of a disease caused by an HIV-1 virus. Diagnostic, prognostic and combined therapeutic kits are also provided.